Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for healthcare industry professionals · Monday, October 15, 2018 · 465,128,570 Articles · 3+ Million Readers

+22% CAGR to Be Achieved by Human Microbiome Market by Extensive market growth

Human Microbiome market

Human Microbiome market

Human Microbiome helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

PUNE, MAHARASHTRA, INDIA, May 24, 2018 / -- The rising incidence of lifestyle diseases at the global level is a strong driver for the microbiome market, as therapeutics may provide an alternative route to tackle the significant healthcare challenges, such as obesity. The increasing occurrence of autoimmune disorders and antibiotic resistance are also important areas, where there is a need for fresh treatment approaches and, for which microbiome therapies may have a significant impact over the next few years. With advancements in precision medicine, personalized nutrition is also playing a crucial role. Almost half of the total chronic disease deaths are attributable to cardiovascular diseases, obesity, and diabetes, as they already affect a large proportion of the population. Hence, this exorbitant increase in the lifestyle diseases across the globe is driving the market for the human microbiome, which is expected to augment in the future.

The global human microbiome market is categorized based on various diseases, applications and by products. The disease segment is further sub-segmented into obesity, diabetes, auto-immune diseases, central nervous system disorders, cancer and diarrhea. Obesity and diarrhea are the largest sub-segments in the global human microbiome market. This is due to increasing lifestyle diseases and aging population. The application segment includes diagnostic and therapeutic applications of the human microbiome. Therapeutic application is the leading sub-segment in the global human microbiome market. This is due rising population and increasing prevalence of diseases. The product segment is further sub-segmented into prebiotic and probiotic, medical food and supplements. Prebiotic and probiotic is the largest sub-segment in this market due to increased potential of these products in the treatment of lifestyle diseases.

Get Sample Copy of this report:

Top Key Vendors:
DuPont, MicroBiome Therapeutics, Osel, Metabiomics Corporation, Enterome Bioscience, Yakult, ViThera Pharmaceuticals, Vedanta BioSciences

This report on the global human microbiome market analyzes the future prospects of the market. The market for diagnostics and therapeutics is independently analyzed as two separate markets within the report. The market for microbiome therapeutics is segmented based on therapeutic area and region, while the market for microbiome diagnostics is segmented on the basis of indication, technology and region.

The report portions the market in light of segments, for example, applications, product type, key regions, and end users of the market. This research report likewise incorporates a projection of the rate of entrance of different items and innovations from the market, alongside the consequences of a definite report on the variables as of now influencing the request volume in the global Human Microbiome market report 2017 over all the provincial fragments. This can help a client in building more grounded decision in the investment process.

To get more information, Ask for Sample PDF illustration with TOC, Tables, Figures and Charts @

Table Of Content:

Chapter 1 Human Microbiome Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Early buyers will receive up to 40% Discount on this report

Shreyas Tanna
Healthcare Intelligence Markets
email us here

Powered by EIN Presswire